Nobody works less or delivers worse results to their members than these guys, they just keep finding the wrong play at the wrong time and providing inferior reports packed with useless info.
Courtesy of James S. earlier post, there are more items to be covered today:
Immunogenicity of ADXS-HER2 in Canine Osteosarcoma ◾Nicola Mason, PhD, BVetMed, Assistant Professor of Medicine, University of Pennsylvania
Effects of Advaxis’ Lm Immunotherapy on the STING Pathway ◾Robert Petit, PhD, Chief Scientific Officer, Advaxis
Cancer Neoepitope Immunotherapy: An Update on ADXS-NEO ◾Robert Petit, PhD, Chief Scientific Officer, Advaxis
Nobody works less or delvers worse results to their members than this service, these guys just keep finding the losing play at the wrong time and providing inferior reports packed with useless info.
This is the genius who said this of CPXX. "cavanyc • Mar 16, 2016 12:17 "ANOTHER SHKRELI POS SCAM FOR SUKERS SO PATHETIC". CPXX now over $15. A fool and his money...
There are companies happy just having partial responses and stable disease. We have complete responses. No reason in the world to have the MC we have at the moment.
I'm sure Arantana would charge top dollar for the vaccine so I can't see why they are not pursuing this with all the energy they have.
Not to belittle the seriousness of this but, when I read the quote, it sounded like a Weekly World News tabloid title. I did find the video. We are on the verge, I truly believe, of a groundbreaking treatment for cancer.
Appears to have changed from "Active, Not Recruiting" to "Recruiting" on 3/13. Do I hear LeGrande gnashing his teeth?
I'm sure we'll see something positive. Thoughts?
"Only 5 in 5,000 drugs that enter preclinical testing progress to human testing. One of these 5 drugs that are tested in people is approved." So it's one in 5 if it gets to human testing.